Experimental drug tested for Life-Threatening fungal infections
Disease control
Terminated
This study tested an experimental drug called APX001 for adults with serious, hard-to-treat fungal infections in the lungs or other organs. It aimed to see if the drug could safely control these dangerous infections in patients who had few other treatment options. The trial was s…
Phase: PHASE2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC